To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05458674
Title Tucatinib+Trastuzumab+Eribulin in HER2+ MBC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Criterium, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado RECRUITING Aurora Colorado 80045 United States Details
George Washington Medical Faculty Associates RECRUITING Washington District of Columbia 20037 United States Details
New Mexico Cancer Care Alliance RECRUITING Albuquerque New Mexico 87131 United States Details
Swedish Cancer Institute RECRUITING Issaquah Washington 98029 United States Details
Cancer Care Northwest RECRUITING Spokane Valley Washington 99216 United States Details
University of Wisconsin Carbone Cancer Center RECRUITING Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field